Germany's Merck KGaA said on Tuesday its lab equipment division and its pharmaceuticals division would be under new ...
Merck & Co. has penned a $300 million biobucks-per-product deal with cancer biotech Epitopea to identify previously secret ...
GlobalData on MSN3d
New CEOs to join Merck KGaA’s executive boardJean-Charles Wirth and Danny Bar-Zohar are set to assume the life science and healthcare CEO roles respectively.
It's been a rough start to 2025 for Merck (NYSE: MRK) shareholders following a less-than-stellar fourth-quarter earnings ...
“What I was doing and under the hood in a lab, now we can do at much larger ... More than the cost of acquiring and implementing a new technology, Merck looks at the technology’s impact.
“Our partnership with Opentrons reinforces our focus to automate and digitalize the lab ... new potential therapeutics.” Customers can place orders for workstations and assay kits from Merck ...
Merck & Co’s – known as MSD outside of the US and Canada – Welireg (belzutifan) has been conditionally approved by the ...
After a slow 2024, dealmaking in the U.S. healthcare sector is picking up. Springworks has a market value of $3 billion.
FRANKFURT, Feb 18 (Reuters) - Germany's Merck KGaA (MRCG.DE), opens new tab said on Tuesday its lab equipment division and its pharmaceuticals division would be under new leadership from June but ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback